Algo version: 0.98b
Proteome Sciences PLC is listed at the LSE Exchange
Proteome Sciences PLC [PRM.L]
LSE Sector: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Is Proteome Sciences PLC stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Proteome Sciences PLC 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was GBP3.25, you would have made a profit of GBP0.100 per share or 3.08%

No, the average daily trading liquidity for Proteome Sciences PLC is GBP53 009 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Proteome Sciences PLC has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.04, the company's ability to pay off the debt is limited. Proteome Sciences PLC has a good net profit margin of 18.19% and should have high tolerances against inflation.

We have calculated the inflation risk for Proteome Sciences PLC to be medium [0.55 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.